Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$6.50 +0.35 (+5.61%)
Closing price 03:58 PM Eastern
Extended Trading
$6.48 -0.02 (-0.31%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BNR vs. VMD, XGN, DCGO, EUDA, SERA, QIPT, CORBF, ATPC, BDSX, and PIII

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), Agape ATP (ATPC), Biodesix (BDSX), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs. Its Competitors

Burning Rock Biotech (NASDAQ:BNR) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Viemed Healthcare has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$70.67M0.99-$47.49M-$1.89-3.44
Viemed Healthcare$224.26M1.11$11.27M$0.3021.07

In the previous week, Viemed Healthcare had 2 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for Viemed Healthcare and 1 mentions for Burning Rock Biotech. Viemed Healthcare's average media sentiment score of 1.17 beat Burning Rock Biotech's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Burning Rock Biotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Viemed Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Burning Rock Biotech has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500.

Viemed Healthcare has a net margin of 5.28% compared to Burning Rock Biotech's net margin of -45.41%. Viemed Healthcare's return on equity of 9.49% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-45.41% -38.33% -25.34%
Viemed Healthcare 5.28%9.49%7.14%

Summary

Viemed Healthcare beats Burning Rock Biotech on 12 of the 13 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$69.89M$2.50B$15.86B$9.46B
Dividend YieldN/A1.62%2.85%4.14%
P/E Ratio-3.4420.0824.4623.99
Price / Sales0.9987.5467.7079.74
Price / CashN/A41.2525.5427.24
Price / Book0.886.396.395.84
Net Income-$47.49M$33.35M$196.72M$265.35M
7 Day Performance11.79%-1.44%-1.39%-1.00%
1 Month Performance92.44%-1.56%-1.95%6.09%
1 Year Performance1.01%55.65%35.18%23.81%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
0.9011 of 5 stars
$6.50
+5.6%
N/A-1.8%$69.89M$70.67M-3.441,390
VMD
Viemed Healthcare
2.9172 of 5 stars
$6.07
+2.4%
N/A-12.0%$234.38M$224.26M20.231,179Positive News
Upcoming Earnings
XGN
Exagen
4.5473 of 5 stars
$8.85
+2.5%
$11.25
+27.1%
+333.8%$189.89M$55.64M-9.94220Earnings Report
Short Interest ↑
DCGO
DocGo
2.9225 of 5 stars
$1.40
+5.3%
$3.56
+154.3%
-56.9%$135.64M$520.50M-70.004,407Upcoming Earnings
EUDA
EUDA Health
1.0905 of 5 stars
$3.03
-4.1%
N/A-22.1%$117.60M$4.01M0.002Gap Up
SERA
Sera Prognostics
0.2102 of 5 stars
$2.59
-4.1%
N/A-68.1%$101.72M$80K-2.76120Upcoming Earnings
QIPT
Quipt Home Medical
2.7448 of 5 stars
$2.41
+4.3%
$2.85
+18.3%
-35.6%$100.36M$245.91M-11.481,200Upcoming Earnings
CORBF
Global Cord Blood
N/A$0.71
flat
N/AN/A$86.30M$196.12M0.001,200Gap Up
ATPC
Agape ATP
0.3495 of 5 stars
$1.39
+3.3%
N/A-52.7%$67.31M$1.29M-2.3240Gap Down
BDSX
Biodesix
3.5673 of 5 stars
$0.38
+5.8%
$1.75
+355.5%
-76.3%$53.23M$71.32M-1.32220News Coverage
Upcoming Earnings
PIII
P3 Health Partners
2.3523 of 5 stars
$7.19
-2.2%
$16.25
+126.0%
-76.0%$52.83M$1.49B-0.15500Gap Down

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners